{"entity":{"type":"insider","cik":"0001835458","url":"/insider/0001835458","json_url":"/insider/0001835458.json","name":"Ragosa Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":16,"first":"2024-01-04","last":"2026-03-11","span_basis":"filed_date"},"name_variants":[{"name":"Ragosa Mark","source":"filing","n_filings":16,"first_seen":"2024-01-04","last_seen":"2026-03-11"}],"transactions":[{"id":5924267,"accession":"0001835458-26-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001835458-26-000006","line_url":"/filing/0001835458-26-000006","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36722.0,"shares_display":"36,722","price_per_share":45.916829693371824,"price_display":"45.92","price_state":"stated","total_value":1686157.82,"total_display":"1,686,157.82","total_whole":"1,686,158","shares_owned_after":12086.0,"shares_owned_after_display":"12,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider","n_lines":2},{"id":6031879,"accession":"0001835458-26-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001835458-26-000004","line_url":"/filing/0001835458-26-000004","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17845.0,"shares_display":"17,845","price_per_share":43.27566377136453,"price_display":"43.28","price_state":"stated","total_value":772254.22,"total_display":"772,254.22","total_whole":"772,254","shares_owned_after":20817.0,"shares_owned_after_display":"20,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider","n_lines":2},{"id":5938057,"accession":"0001835458-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001835458-26-000002","line_url":"/filing/0001835458-26-000002#line-1","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":41.89,"price_display":"41.89","price_state":"stated","total_value":502680.0,"total_display":"502,680.00","total_whole":"502,680","shares_owned_after":19086.0,"shares_owned_after_display":"19,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-09","scope":"insider"},{"id":4323156,"accession":"0001835458-25-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001835458-25-000007","line_url":"/filing/0001835458-25-000007#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42841.0,"shares_display":"42,841","price_per_share":41.49,"price_display":"41.49","price_state":"stated","total_value":1777473.09,"total_display":"1,777,473.09","total_whole":"1,777,473","shares_owned_after":31086.0,"shares_owned_after_display":"31,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":5100367,"accession":"0001835458-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001835458-25-000005","line_url":"/filing/0001835458-25-000005#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19900.0,"shares_display":"19,900","price_per_share":40.94,"price_display":"40.94","price_state":"stated","total_value":814706.0,"total_display":"814,706.00","total_whole":"814,706","shares_owned_after":31086.0,"shares_owned_after_display":"31,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4155799,"accession":"0001835458-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001835458-25-000003","line_url":"/filing/0001835458-25-000003#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":4100.0,"total_display":"4,100.00","total_whole":"4,100","shares_owned_after":31086.0,"shares_owned_after_display":"31,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":4075136,"accession":"0001415889-25-021178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021178","line_url":"/filing/0001415889-25-021178#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18889.0,"shares_display":"18,889","price_per_share":32.89,"price_display":"32.89","price_state":"stated","total_value":621259.21,"total_display":"621,259.21","total_whole":"621,259","shares_owned_after":27009.0,"shares_owned_after_display":"27,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-06","scope":"insider"},{"id":4051098,"accession":"0001415889-25-015778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-015778","line_url":"/filing/0001415889-25-015778#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18299.0,"shares_display":"18,299","price_per_share":28.8,"price_display":"28.80","price_state":"stated","total_value":527011.2,"total_display":"527,011.20","total_whole":"527,011","shares_owned_after":27009.0,"shares_owned_after_display":"27,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":4641062,"accession":"0001415889-25-011690","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-25-011690","line_url":"/filing/0001415889-25-011690#line-8","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25141.0,"shares_display":"25,141","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":698919.8,"total_display":"698,919.80","total_whole":"698,920","shares_owned_after":27009.0,"shares_owned_after_display":"27,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-01","scope":"insider"},{"id":4641048,"accession":"0001415889-25-011690","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-011690","line_url":"/filing/0001415889-25-011690#line-5","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21254.0,"shares_display":"21,254","price_per_share":26.95,"price_display":"26.95","price_state":"stated","total_value":572795.3,"total_display":"572,795.30","total_whole":"572,795","shares_owned_after":27009.0,"shares_owned_after_display":"27,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-30","filed_date":"2025-05-01","scope":"insider"},{"id":4641041,"accession":"0001415889-25-011690","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-011690","line_url":"/filing/0001415889-25-011690#line-3","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42000.0,"shares_display":"42,000","price_per_share":25.61,"price_display":"25.61","price_state":"stated","total_value":1075620.0,"total_display":"1,075,620.00","total_whole":"1,075,620","shares_owned_after":27009.0,"shares_owned_after_display":"27,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-29","filed_date":"2025-05-01","scope":"insider"},{"id":4050831,"accession":"0001415889-25-008846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008846","line_url":"/filing/0001415889-25-008846#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15944.0,"shares_display":"15,944","price_per_share":23.11,"price_display":"23.11","price_state":"stated","total_value":368465.84,"total_display":"368,465.84","total_whole":"368,466","shares_owned_after":23382.0,"shares_owned_after_display":"23,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider"},{"id":5193412,"accession":"0001415889-25-008622","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-008622","line_url":"/filing/0001415889-25-008622#line-6","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8879.0,"shares_display":"8,879","price_per_share":23.1,"price_display":"23.10","price_state":"stated","total_value":205104.9,"total_display":"205,104.90","total_whole":"205,105","shares_owned_after":23382.0,"shares_owned_after_display":"23,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-19","scope":"insider"},{"id":5193406,"accession":"0001415889-25-008622","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-008622","line_url":"/filing/0001415889-25-008622#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11464.0,"shares_display":"11,464","price_per_share":23.1,"price_display":"23.10","price_state":"stated","total_value":264818.4,"total_display":"264,818.40","total_whole":"264,818","shares_owned_after":23382.0,"shares_owned_after_display":"23,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":5193356,"accession":"0001415889-25-008115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008115","line_url":"/filing/0001415889-25-008115#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36372.0,"shares_display":"36,372","price_per_share":22.25,"price_display":"22.25","price_state":"stated","total_value":809277.0,"total_display":"809,277.00","total_whole":"809,277","shares_owned_after":22958.0,"shares_owned_after_display":"22,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":3179348,"accession":"0001415889-24-028844","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-028844","line_url":"/filing/0001415889-24-028844#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18860.0,"shares_display":"18,860","price_per_share":21.38,"price_display":"21.38","price_state":"stated","total_value":403226.8,"total_display":"403,226.80","total_whole":"403,227","shares_owned_after":22958.0,"shares_owned_after_display":"22,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-10","scope":"insider"},{"id":3179337,"accession":"0001415889-24-028844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028844","line_url":"/filing/0001415889-24-028844#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8969.0,"shares_display":"8,969","price_per_share":21.27,"price_display":"21.27","price_state":"stated","total_value":190770.63,"total_display":"190,770.63","total_whole":"190,771","shares_owned_after":22958.0,"shares_owned_after_display":"22,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-10","scope":"insider"},{"id":2954952,"accession":"0001415889-24-028431","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-028431","line_url":"/filing/0001415889-24-028431#line-6","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1123.0,"shares_display":"1,123","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":23863.75,"total_display":"23,863.75","total_whole":"23,864","shares_owned_after":22958.0,"shares_owned_after_display":"22,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-05","scope":"insider"},{"id":2954942,"accession":"0001415889-24-028431","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-028431","line_url":"/filing/0001415889-24-028431#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5024.0,"shares_display":"5,024","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":106760.0,"total_display":"106,760.00","total_whole":"106,760","shares_owned_after":22958.0,"shares_owned_after_display":"22,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-05","scope":"insider"},{"id":2954934,"accession":"0001415889-24-028431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028431","line_url":"/filing/0001415889-24-028431#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8969.0,"shares_display":"8,969","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":192385.05,"total_display":"192,385.05","total_whole":"192,385","shares_owned_after":22958.0,"shares_owned_after_display":"22,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-05","scope":"insider"},{"id":2222833,"accession":"0001415889-24-020106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-020106","line_url":"/filing/0001415889-24-020106#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24248.0,"shares_display":"24,248","price_per_share":24.79,"price_display":"24.79","price_state":"stated","total_value":601107.92,"total_display":"601,107.92","total_whole":"601,108","shares_owned_after":19253.0,"shares_owned_after_display":"19,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-23","filed_date":"2024-07-25","scope":"insider"},{"id":2995324,"accession":"0001415889-24-000609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000609","line_url":"/filing/0001415889-24-000609#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001835458","owner_name":"Ragosa Mark","owner_display_name":"Ragosa Mark","owner_url":"/insider/0001835458","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":15632.0,"shares_owned_after_display":"15,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":16,"first_seen":"2024-01-04","last_seen":"2026-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001835458","retrieved_at":"2026-08-24T06:24:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}